Exploring bias risks in artificial intelligence and targeted medicines manufacturing
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Exploring bias risks in artificial intelligence and targeted medicines manufacturing ; volume:25 ; number:1 ; day:17 ; month:10 ; year:2024 ; pages:1-10 ; date:12.2024
BMC medical ethics ; 25, Heft 1 (17.10.2024), 1-10, 12.2024
- Urheber
-
Nwebonyi, Ngozi
McKay, Francis
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12910-024-01112-1
- URN
-
urn:nbn:de:101:1-2501062104518.582644340279
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nwebonyi, Ngozi
- McKay, Francis
- SpringerLink (Online service)
Ähnliche Objekte (12)
Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives
Manufacturing pharmaceutical medicines in a regulated environment - an auditor’s perspective
India's road to independence in manufacturing active pharmaceutical ingredients: Focus on essential medicines
Network medicines™
Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias’ in access to imported medicines in Tanzania and its policy implications
Translational medicines “Ecosystem”
Evaluation of Risks and Security Controls for Industrial Components within Connected Manufacturing
Risks and management of hypertension in cancer patients undergoing targeted therapy: a review
Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
Journal of natural medicines
Small and Medium Enterprises and Global Risks: Evidence from Manufacturing SMEs in Turkey
Monetary Quantification of Supply Risks of Manufacturing Enterprises : Discrete Event Simulation Based Approach
Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives
Manufacturing pharmaceutical medicines in a regulated environment - an auditor’s perspective
India's road to independence in manufacturing active pharmaceutical ingredients: Focus on essential medicines
Network medicines™
Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias’ in access to imported medicines in Tanzania and its policy implications
Translational medicines “Ecosystem”
Evaluation of Risks and Security Controls for Industrial Components within Connected Manufacturing
Risks and management of hypertension in cancer patients undergoing targeted therapy: a review
Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
Journal of natural medicines
Small and Medium Enterprises and Global Risks: Evidence from Manufacturing SMEs in Turkey
Monetary Quantification of Supply Risks of Manufacturing Enterprises : Discrete Event Simulation Based Approach
Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives
Manufacturing pharmaceutical medicines in a regulated environment - an auditor’s perspective
India's road to independence in manufacturing active pharmaceutical ingredients: Focus on essential medicines
Network medicines™
Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias’ in access to imported medicines in Tanzania and its policy implications
Translational medicines “Ecosystem”
Evaluation of Risks and Security Controls for Industrial Components within Connected Manufacturing
Risks and management of hypertension in cancer patients undergoing targeted therapy: a review
Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
Journal of natural medicines
Small and Medium Enterprises and Global Risks: Evidence from Manufacturing SMEs in Turkey